Toshihide Maeda
Overview
Explore the profile of Toshihide Maeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taguchi D, Shirakami Y, Sakai H, Minowa D, Miwa T, Maeda T, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940750
Cholangiocarcinoma-associated mortality has been increasing over the past decade. The sodium-glucose cotransporter 2 inhibitor, canagliflozin, has demonstrated anti-tumor effects against several types of cancers; however, studies examining its potential impact...
2.
Maeda T, Shirakami Y, Taguchi D, Miwa T, Kubota M, Sakai H, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519191
Colorectal cancer represents one of the most serious complications of inflammatory bowel disease. The NLRP3 inflammasome plays a pivotal role in the onset and progression of inflammatory bowel disease and...
3.
Taguchi D, Shirakami Y, Sakai H, Maeda T, Miwa T, Kubota M, et al.
Nutrients
. 2024 Aug;
16(15).
PMID: 39125385
More effective treatments for hepatitis viral infections have led to a reduction in the incidence of liver cirrhosis. A high-fat diet can lead to chronic hepatitis and liver fibrosis, but...
4.
Shirakami Y, Kato J, Ohnishi M, Taguchi D, Maeda T, Ideta T, et al.
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834032
Cholangiocarcinoma is the second most common primary cancer of the liver and has a poor prognosis. Various animal models, including carcinogen-induced and genetically engineered rodent models, have been established to...
5.
Nakahata Y, Hanai T, Miwa T, Maeda T, Imai K, Suetsugu A, et al.
J Clin Med
. 2023 Apr;
12(8).
PMID: 37109203
Selenium is an essential trace element to maintain good health. This retrospective study investigated the prevalence of selenium deficiency and its effect on overt hepatic encephalopathy (OHE) in patients with...
6.
Hanai T, Nishimura K, Miwa T, Maeda T, Imai K, Suetsugu A, et al.
JGH Open
. 2023 Mar;
7(3):208-214.
PMID: 36968562
Background And Aim: Polypharmacy and sarcopenia are increasing public health problems worldwide. However, data on the prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis...
7.
Shirakami Y, Kato J, Maeda T, Ideta T, Imai K, Sakai H, et al.
J Gastroenterol Hepatol
. 2023 Mar;
38(5):800-808.
PMID: 36890117
Background And Aim: Although liver diseases, including non-alcoholic steatohepatitis, are associated with skeletal muscle atrophy, the mechanism behind their association has not been fully elucidated. In this study, the effects...
8.
Miwa T, Hanai T, Nishimura K, Maeda T, Tajirika S, Imai K, et al.
PLoS One
. 2022 Nov;
17(11):e0277829.
PMID: 36449492
Aim: Covert hepatic encephalopathy (CHE) adversely affects clinical outcomes in patients with liver cirrhosis, although its diagnosis is difficult. This study aimed to establish a simple CHE screening model based...
9.
Hanai T, Nishimura K, Miwa T, Maeda T, Nakahata Y, Imai K, et al.
J Gastroenterol
. 2022 Sep;
57(12):981-989.
PMID: 36173512
Background: Covert hepatic encephalopathy (CHE) adversely affects the clinical outcomes of patients with cirrhosis but remains largely undiagnosed and untreated. Although the Stroop test is a useful method for CHE...
10.
Miwa T, Hanai T, Nishimura K, Unome S, Maeda T, Ogiso Y, et al.
Hepatol Res
. 2022 Jul;
52(11):928-936.
PMID: 35861232
Aim: The Global Leadership Initiative on Malnutrition (GLIM) criteria, a newly developed global consensus around core diagnostic criteria for malnutrition, needs validation studies for use in daily clinical settings. This...